C4X Discovery Holdings plc
(“C4XD” or the “Company”)
Result of General Meeting and Open Offer
Issue of Equity
5 October 18 - C4X Discovery Holdings plc (AIM: C4XD), a pioneering drug discovery company, today announces that at the General Meeting held earlier today in connection with the Company’s Placing and Open Offer at a price of 90 pence per new Ordinary Share, details of which were announced on 18 September 2018, all resolutions put to shareholders were duly passed.
The Company also announces that it has received valid acceptances in respect of 99,563 Open Offer Shares from Qualifying Shareholders, including applications under the Excess Application Facility. This represents approximately 9% of the 1,108,454 Open Offer Shares offered. As a consequence and following the passing of the resolutions at the General Meeting, and conditional on First Admission and Second Admission, the Company has raised £10.1 million (before expenses) in aggregate through the Placing and Open Offer.
Applications have been made for the 11,111,111 Placing Shares and 99,563 Open Offer Shares to be admitted to trading on AIM. It is expected that First Admission of the 3,379,997 Eligible Shares will take place at 8.00 a.m. on 8 October 2018 and Second Admission of the 7,731,114 General Placing Shares and 99,563 Open Offer Shares will take place at 8.00 a.m. on 9 October 2018. The Placing Shares and Open Offer Shares will rank pari passu with the existing Ordinary Shares.
Following Second Admission, the Company's issued share capital will consist of 57,765,761 Ordinary Shares. There are no Ordinary Shares held in treasury. Therefore, in accordance with the FCA's Disclosure and Transparency Rule 5.6.1, the Company confirms that as at 9 October 2018, the total number of voting rights in the Company will be 57,765,761. Following Second Admission, this figure may be used by shareholders as the denominator for the calculations by which they determine whether they are required to notify their interest in, or a change to their interest in, C4XD under the Disclosure Guidance and Transparency Rules.
The capitalised terms used in this announcement have the meaning as defined in the announcement published by the Company at 1.53 p.m. on 18 September 2018 unless otherwise stated.